Stability of a second-generation cephalosporin veterinary mastitis formulation after electron beam irradiation

AAPS PharmSciTech

Volumn 2, Issue 4, 2001, Pages

  Johns, Pamela J ^a   Turberg, Michael ^a   Willard, Kevin ^a   Matagne, Daniel ^b   Cheesman, David ^c  

^a ELANCO ANIMAL HEALTH   (United States)

^b Eli Lilly Benelux   (Belgium)

^c Lilly Technology Center   (United States)

Author keywords

Cephalosporin; Chemical stability; E beam irradiation; Electron beam irradiation; Mastitis

Indexed keywords

CEPHALOSPORIN DERIVATIVE; CEPHEM 1; POLYETHYLENE; UNCLASSIFIED DRUG; 7 (1 PENTAFLUOROPHENOXYACETAMIDO) 3 (2 (5 METHYL 1,3,4 THIODIAZOLYL)THIOMETHYL) DELTA(3) CEPHEM 4 CARBOXYLIC ACID; 7-(1-PENTAFLUOROPHENOXYACETAMIDO)-3-(2-(5-METHYL-1,3,4-THIODIAZOLYL)THIOMETHYL)-DELTA(3)-CEPHEM-4-CARBOXYLIC ACID; ANTIINFECTIVE AGENT;

ARTICLE; CATTLE DISEASE; CONTAINER; CONTROLLED STUDY; DRUG FORMULATION; DRUG IDENTIFICATION; DRUG LABELING; DRUG MANUFACTURE; DRUG STABILITY; DRUG STORAGE; DRUG STRUCTURE; ELECTRON BEAM; MASTITIS; RADIATION DOSE; STATISTICAL SIGNIFICANCE; STORAGE TEMPERATURE; SYRINGE; ANIMAL; CATTLE; CHEMISTRY; FEMALE; INSTRUMENT STERILIZATION; RADIATION EXPOSURE;

ANIMALS; ANTI-BACTERIAL AGENTS; CATTLE; CEPHALOSPORINS; DRUG STABILITY; FEMALE; MASTITIS, BOVINE; STERILIZATION;

EID: 23144443874     PISSN: 15309932     EISSN: 15309932     Source Type: Journal    
DOI: 10.1007/BF02830563     Document Type: Article

References (9)

1. United States Food and Drug Administration, Irradiation in the Production, Processing and Handling of Food, Federal Register 21 CFR Part 179 page 64108, December 1997.
2. Carlson K, Williams C, Lambert B, Tang F. Guidant Corporations Installation of the SureBeamr® On-Site System, Radiation Phys. Chem., 2000; 57 (3-6): 619-623
3. Van Lancker M, Herer A, Cleland MR, Jongen Y, Abs M.. The ion beam application Rhodotron: an industrial high-voltage high-powered electron beam accelerator for polymers radiation processing. Nucl Instrum Methods Phys Res. 1999;Sect. B, 151(1-4):242-246.
4. Li S, Zamansky I, Orlov I, Tyle P, Roy SD Preformulation studies for the development of a parenteral liquid formulation of an antitumor agent, AG337, PDA J. PharmSciTech. 1997;51(5):181-186.
5. Boess C, Bogl KW. Influence of radiation treatment on pharmaceuticals-a review: alkaloids, morphine derivatives, and antibiotics. Drug Dev Ind Pharm. 1996;22(6):495-529.
6. Jacobs GP. Stability of cefazolin and other new cephalosporins following gamma irradiation. Int J Pharm. 1983;17(1):29-38.
7. Health Canada. Process Validation: Irradiation Sterilization for Pharmaceuticals. Available at: www.hc-sc.gc.ca/hpb-dgps/therapeutic. Accessed October, 2001.
8. Stern M. Packaging materials issues in irradiation processing of foods. in Proceedings Polyolefins XII International Conference, Houston, TX, Society of Plastics Engineers, February 2000.
9. Lencioni E, Travagli V, La Rosa C, Pitotti A, Fuochi PG. Sterilization of pharmaceutical products by accelerated electrons. Boll Chim Farm. 1995;134(3):146-149.